MEKOPHAR BP

Business Nature: Manufacturer (Factory)

Company Profile:

Mekophar Chemical Pharmaceutical Joint Stock Company is a leading pharmaceutical enterprise based in Vietnam. Established in 1975, the company specializes in the research, development, and manufacturing of high-quality pharmaceutical products. Its core business operations encompass the production of finished dosage forms, including tablets, capsules, injectables, and sterile powders, as well as the manufacturing of Active Pharmaceutical Ingredients (APIs).

Mekophar operates modern manufacturing facilities that strictly adhere to WHO-GMP (World Health Organization - Good Manufacturing Practice) standards. The company is well-regarded for its commitment to innovation, quality control, and international collaboration. Beyond its domestic market presence, Mekophar exports its products to various countries across Asia, Africa, and Europe, positioning itself as a key player in the regional pharmaceutical industry.

Mekophar Chemical Pharmaceutical Joint Stock Company (Mekophar) produces and distributes a wide range of pharmaceutical and healthcare products. Their primary product categories include:

Pharmaceutical Products:

Antibiotics and anti-infective agents

Analgesics and antipyretics

Anti-inflammatory medications

Cardiovascular drugs

Gastrointestinal medications

Respiratory system drugs

Vitamin and mineral supplements

Dermatological creams and ointments

Biological and Biotechnology Products:

Platelet-rich plasma (PRP) kits

Stem cell-related biological products

Culture media and reagents for laboratory use

Healthcare and Consumer Goods:

Antiseptic solutions

Medical supplies and disposables

Nutritional supplements

Health functional foods

Mekophar also operates as a contract manufacturing organization (CMO) and provides raw material processing services for both domestic and international pharmaceutical companies.